eRAPID cognitive interview study
- Conditions
- Colorectal Cancer, breast cancer, gynaecological cancer, renal cancer, lung cancerCancerMalignant neoplasms of independent (primary) multiple sites
- Registration Number
- ISRCTN58893387
- Lead Sponsor
- niversity of Leeds (UK)
- Brief Summary
2016 Results article in https://www.ncbi.nlm.nih.gov/pubmed/27551774 results
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
1. Undergoing chemotherapy and biological treatment with curative or palliative intent
2. Able and willing to give informed consent
3. Have gynaecological, breast, lung, renal and colorectal cancer
4. Male or female
5. Lower Age Limit 18 years
1. If taking part in other studies run by the group
2. If not able to read and understand English
3. If exhibiting overt psychopathology or serious cognitive dysfunction which would impede their being able to take part in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A bank of adverse event items
- Secondary Outcome Measures
Name Time Method o secondary outcome measures